United States - English - NLM (National Library of Medicine)

organon usa inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate 250 ug in 0.5 ml - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components including dry natural rubber/latex (see how supplied). - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

theramex australia pty ltd - ganirelix, quantity: 0.25 mg - injection, solution - excipient ingredients: glacial acetic acid; water for injections; mannitol; sodium hydroxide - for the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques

European Union - English - EMA (European Medicines Agency)

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - pituitary and hypothalamic hormones and analogues - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).

United States - English - NLM (National Library of Medicine)

organon llc - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components including dry natural rubber/latex which may be contained in the rigid needle shield (see how supplied). - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).

United States - English - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components including dry natural rubber/latex (see how supplied ). - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions ).

United States - English - NLM (National Library of Medicine)

amphastar pharmaceuticals, inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).

United States - English - NLM (National Library of Medicine)

gland pharma limited - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: • known hypersensitivity to ganirelix acetate or to any of its components.   • known hypersensitivity to gnrh or any other gnrh analog. • known or suspected pregnancy (see precautions).

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).